358 related articles for article (PubMed ID: 34683334)
1. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
2. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
5. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Cardiovascular Health and Disease.
Tang WH; Kitai T; Hazen SL
Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
[TBL] [Abstract][Full Text] [Related]
8. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and myocardial fibrosis.
Xu H; Yang F; Bao Z
Eur J Pharmacol; 2023 Feb; 940():175355. PubMed ID: 36309048
[TBL] [Abstract][Full Text] [Related]
10. The role of intestinal microbiota in cardiovascular disease.
Jin M; Qian Z; Yin J; Xu W; Zhou X
J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
[TBL] [Abstract][Full Text] [Related]
11. Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment.
Hoseini-Tavassol Z; Hasani-Ranjbar S
J Diabetes Metab Disord; 2021 Jun; 20(1):1095-1097. PubMed ID: 34178875
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
13. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
Zhu J; Lyu J; Zhao R; Liu G; Wang S
Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Heart, Vascular Injury.
Zeng C; Tan H
Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
16. The gut-immune axis during hypertension and cardiovascular diseases.
Dinakis E; O'Donnell JA; Marques FZ
Acta Physiol (Oxf); 2024 Jun; ():e14193. PubMed ID: 38899764
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Cardiovascular Diseases: A Critical Review.
Anselmi G; Gagliardi L; Egidi G; Leone S; Gasbarrini A; Miggiano GAD; Galiuto L
Cardiol Rev; 2021 Jul-Aug 01; 29(4):195-204. PubMed ID: 32639240
[TBL] [Abstract][Full Text] [Related]
18. The role of the gut microbiota in health and cardiovascular diseases.
Wang L; Wang S; Zhang Q; He C; Fu C; Wei Q
Mol Biomed; 2022 Oct; 3(1):30. PubMed ID: 36219347
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation.
Tousoulis D; Guzik T; Padro T; Duncker DJ; De Luca G; Eringa E; Vavlukis M; Antonopoulos AS; Katsimichas T; Cenko E; Djordjevic-Dikic A; Fleming I; Manfrini O; Trifunovic D; Antoniades C; Crea F
Cardiovasc Res; 2022 Dec; 118(16):3171-3182. PubMed ID: 35420126
[TBL] [Abstract][Full Text] [Related]
20. The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health.
Bui TVA; Hwangbo H; Lai Y; Hong SB; Choi YJ; Park HJ; Ban K
Korean Circ J; 2023 Aug; 53(8):499-518. PubMed ID: 37525495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
